Autres langues ProPhase Labs, Inc.

Actions

PRPH

US74345W1080

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
5,31 ^USD	+2,31 %		+7,27 %	+17,48 %

16/04	ProPhase Labs, Inc. dévoile le projet ZenQ-AI	CI
15/03	Transcript : ProPhase Labs, Inc., 2023 Earnings Call, Mar 15, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9	14:01
ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024	25/04
Health Care Ticks Up After UnitedHealth Earnings -- Health Care Roundup	16/04
ProPhase Labs Unveils Project ZenQ-AI	16/04
ProPhase Labs, Inc. Unveils Project ZenQ-AI	16/04
ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024	10/04
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	02/04
MENADNA and ProPhase Labs' (NASDAQ: PRPH) Wholly-Owned Subsidiary, Nebula Genomics, Announce Strategic Partnership to Enhance Genomic Testing in Jordan, Oman and Iraq	18/03
ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives	15/03
ProPhase Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
North American Morning Briefing : Inflation -2-	15/03
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024	08/03
ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART	20/02
Prophase Labs, Inc. Announces Important Developments in the Company?s Efforts to Commercialize Its Novel Be-Smart Esophageal Cancer Diagnostic Test	20/02
ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir	14/02
ProPhase Labs, Inc. Announces Preliminary Positive Results for Dietary Supplement Equivir	14/02
Sidus Space Appoints Bill White as Chief Financial Officer	09/02
ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics	30/01
Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts	23/01
ProPhase Labs Names Jed Latkin as Chief Operating Officer	04/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ProPhase Labs, Inc.

Actions

PRPH

US74345W1080

Autres langues

Filtres